Salvage therapy combining high-dose cytarabine with amsacrine in refractory acute myeloid leukemia (AML): analysis of prognostic factors

Very High Dose Cytarabine as Salvage Therapy for Relapsed or Refractory Acute Myeloid Leukemia in the Setting of Intensified Anthracycline Induction and Post Stem-Cell Transplantation

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2015.04.028 ◽

2015 ◽

Vol 15 ◽

pp. S184

Author(s):

Gilad Itchaki ◽

Ofir Wolach ◽

Michal Bar-Natan ◽

Moshe Yeshurun ◽

Ron Ram ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Salvage Therapy ◽

Myeloid Leukemia ◽

High Dose ◽

High Dose Cytarabine ◽

Very High ◽

High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia-is more better or more of the same?

Hematological Oncology ◽

10.1002/hon.2191 ◽

2015 ◽

Vol 34 (1) ◽

pp. 28-35 ◽

Cited By ~ 10

Author(s):

Ofir Wolach ◽

Gilad Itchaki ◽

Michal Bar-Natan ◽

Moshe Yeshurun ◽

Ron Ram ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Salvage Therapy ◽

Myeloid Leukemia ◽

High Dose ◽

High Dose Cytarabine ◽

Efficacy and Safety of Azacytidine in combination with fludarabine and high-dose cytarabine with G-CSF (FLAG) in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2021.07.019 ◽

2021 ◽

Author(s):

Ibraheem H. Motabi ◽

Shaima M. Al Aoun ◽

Maged Al-Ammari ◽

Belal M. Albtoosh ◽

Shahid Iqbal ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

High Dose ◽

Efficacy And Safety ◽

Open Label ◽

High Dose Cytarabine ◽

Open Label Phase ◽

Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms

Haematologica ◽

10.3324/haematol.2018.204792 ◽

2018 ◽

Vol 104 (4) ◽

pp. e143-e146 ◽

Cited By ~ 6

Author(s):

Anna B. Halpern ◽

Megan Othus ◽

Emily M. Huebner ◽

Bart L. Scott ◽

Paul C. Hendrie ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase I ◽

Myeloid Leukemia ◽

High Dose ◽

High Grade ◽

Myeloid Neoplasms ◽

High Dose Cytarabine ◽

PF271 USING NEXT-GENERATION SEQUENCING TO PREDICT RESPONSE TO SALVAGE CHEMOTHERAPY WITH HIGH DOSE CYTARABINE AND MITOXANTRONE IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA PATIENTS

HemaSphere ◽

10.1097/01.hs9.0000559296.13095.e4 ◽

2019 ◽

Vol 3 (S1) ◽

pp. 87

Author(s):

J. Canaani ◽

M. Nagar-Marciano ◽

A. Shimoni ◽

I. Danilesko ◽

R. Yerushalmi ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Next Generation Sequencing ◽

Myeloid Leukemia ◽

Salvage Chemotherapy ◽

High Dose ◽

Next Generation ◽

High Dose Cytarabine ◽

Generation Sequencing ◽

Phase I study of GTI-2040, a ribonucleotide reductase antisense, with high dose cytarabine in patients with relapsed/refractory acute myeloid leukemia

Leukemia & Lymphoma ◽

10.3109/10428194.2013.838764 ◽

2013 ◽

Vol 55 (6) ◽

pp. 1332-1336 ◽

Cited By ~ 5

Author(s):

Rebecca B. Klisovic ◽

William Blum ◽

Zhongfa Liu ◽

Zhiliang Xie ◽

Cheryl Kefauver ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Phase I ◽

Ribonucleotide Reductase ◽

Myeloid Leukemia ◽

Phase I Study ◽

High Dose ◽

High Dose Cytarabine ◽

Efficacy and cost-effectiveness of clofarabine with high-dose cytarabine for treatment of relapsed/refractory acute myeloid leukemia (R/R AML).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e19009 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e19009-e19009

Author(s):

Sara Nunnery ◽

Dorothy Wang ◽

Marisela Tan ◽

Richard Fong ◽

Mimi Ming Lo ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Cost Effectiveness ◽

Myeloid Leukemia ◽

High Dose ◽

High Dose Cytarabine ◽

Efficacy and feasibility of cyclophosphamide combined with intermediate- dose or high-dose cytarabine for relapsed and refractory acute myeloid leukemia (AML)

Journal of Cancer Research and Clinical Oncology ◽

10.1007/s00432-014-1666-7 ◽

2014 ◽

Vol 140 (8) ◽

pp. 1391-1397 ◽

Cited By ~ 4

Author(s):

Ulf Schnetzke ◽

Peter Fix ◽

Baerbel Spies-Weisshart ◽

Karin Schrenk ◽

Anita Glaser ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

High Dose ◽

High Dose Cytarabine ◽

Acute Myeloid ◽

Intermediate Dose

Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia

International Journal of Hematology ◽

10.1007/s12185-019-02606-0 ◽

2019 ◽

Vol 109 (4) ◽

pp. 418-425

Author(s):

Nahoko Hatsumi ◽

◽

Shuichi Miyawaki ◽

Takahiro Yamauchi ◽

Akihiro Takeshita ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

High Dose ◽

Granulocyte Colony Stimulating Factor ◽

Colony Stimulating Factor ◽

High Dose Cytarabine ◽

Stimulating Factor ◽

Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors

Leukemia Research ◽

10.1016/s0145-2126(02)00089-9 ◽

2003 ◽

Vol 27 (3) ◽

pp. 205-214 ◽

Cited By ~ 16

Author(s):

Emmanuelle Tavernier ◽

Quoc-Hung Le ◽

Mohamed Elhamri ◽

Xavier Thomas

Keyword(s):

Acute Myeloid Leukemia ◽

Prognostic Factors ◽

Salvage Therapy ◽

Myeloid Leukemia ◽

Prediction Of Outcome ◽